- OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology
- OmniAb to Participate in the Jefferies Global Healthcare Conference
- OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston Summit
- OmniAb Reports First Quarter 2024 Financial Results and Business Highlights
- OmniAb to Participate in Five Investor Conferences in May
- OmniAb to Report First Quarter 2024 Financial Results on May 9
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.67 |
---|---|
High | 3.74 |
Low | 3.61 |
Bid | 3.51 |
Offer | 3.86 |
Previous close | 3.67 |
Average volume | 1.02m |
---|---|
Shares outstanding | 117.62m |
Free float | 94.79m |
P/E (TTM) | -- |
Market cap | 431.65m USD |
EPS (TTM) | -0.634 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 18:00 BST.
More ▼